Technology News

Verséa Ophthalmics announced the distribution of its T-POC Total IgE Immunoassay Kit, a tear-based point-of-care test for the diagnosis and management of ocular surface disease.

OCT imaging is extremely valuable in the diagnosis and management of retinal conditions, providing high-resolution and repeatable images of retinal structures.

The American Academy of Ophthalmology recently expanded the depth and breadth of the IRIS Registry by including data from approximately 3.5 million real-world patient images.

AI algorithms have the potential to infer race not only from color retinal fundus images but also from grayscale retinal vessel maps that eliminate any possibility for humans to infer race, according to a study.

Eyenuk received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system for autonomous detection of diabetic retinopathy, according to a press release.

WASHINGTON — In this Healio video, Jeffry Gerson, OD, FAAO, shares results from the LIGHTSITE III clinical trial, which evaluated photobiomodulation treatment in patients with dry age-related macular degeneration.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, Bill Carpou, CEO of Octane, discusses highlights from the meeting, including Haystax, an AI-driven investment tool.

Peripapillary retinal nerve fiber layer thickness and ganglion cell/inner plexiform layer volume are key OCT markers of neurodegeneration and disability in patients with multiple sclerosis, according to data in the Journal of Neurology.

NEWPORT BEACH, Calif. — In this Healio Video Perspective from Octane’s Ophthalmology Tech Forum, David E.I. Pyott, CBE, discusses how the meeting has evolved as a center for innovation across the ophthalmic industry.

The FDA has given 510(k) clearance to iHealthScreen’s iPredict Eye Screening System, an AI-powered screening tool for age-related macular degeneration in patients aged 50 years and older, according to a company press release.